Rybelsus® and bloating

Swelling and gas in the product information

The US label lists these reactions in a sentence under its main table, because they stayed below 5% ^[1]. Canada includes them in its table, which starts at 1% ^[3]. Both draw on the two placebo-controlled trials the US label calls Trial 1 and Trial 6 and Canada calls PIONEER 1 and PIONEER 8 ^[1][3]. Burping has its own page; it is shown here for comparison.

Bloating, distension and what the labels count

NIH separates two things people often call bloating. Bloating is the sensation of fullness or swelling; distension is when the belly measurably grows. Only about half of people who feel bloated also have distension ^[5]. The labels report distension and flatulence, so the figures may not capture people who felt bloated without visible swelling.

The numbers are small and do not move together. Distension rose with strength, from 2% to 3%, while flatulence went the other way, 2% on 7 mg and 1% on 14 mg ^[1]. On placebo, nobody reported flatulence at all, so even low percentages on the tablets stand out. Because one person may have reported more than one term, the rows cannot be added into a single bloating figure.

Reports from outside the trials

A 2024 study of US FDA reports and online patient reviews, covering tablet and injected semaglutide together, found 576 reports of abdominal distension and 419 of flatulence in the FDA database; in the reviews, flatulence was mentioned 55 times and distension 47 times ^[4]. These counts reflect what people chose to report and cannot give a rate or show cause ^[4].

After approval, delayed stomach emptying has also been reported with the tablets in Canada, and Europe lists it as an uncommon reaction ^[2][3].

Why the tablet may leave you bloated

• Supported by the labels: semaglutide slows the early emptying of the stomach after meals ^[1], and Europe lists delayed gastric emptying among its reactions ^[2].
• A likely link, not measured: constipation was reported by 5% to 6% on the tablets ^[1], and MedlinePlus names constipation as a common cause of bloating ^[7]. No Rybelsus® analysis has checked how often the two came together.
• From general physiology: NIH explains that gas comes from swallowed air and from gut bacteria breaking down carbohydrates that were not fully digested ^[5]. Whether semaglutide changes this has not been studied for the tablet.

Other things that cause bloating

MedlinePlus lists swallowing air, constipation, reflux, irritable bowel syndrome, lactose intolerance, overeating, bacterial overgrowth in the small bowel and weight gain as common causes ^[7]. Of particular interest with diabetes, it names acarbose, an oral diabetes medicine, and products containing lactulose or sorbitol ^[7]. More serious causes include fluid in the abdomen, coeliac disease, ovarian cancer and a pancreas that does not make enough digestive enzymes ^[7]. NIH adds gastroparesis and blockage of the digestive tract ^[5].

What NIH and MedlinePlus suggest

To swallow less air, NIH suggests avoiding chewing gum, hard sweets, fizzy drinks and straws, not talking while eating, eating more slowly and sitting down for meals ^[6]. It also mentions smaller, more frequent meals and cutting back on foods that bring on gas for you, such as beans, lentils, cabbage-family vegetables, and foods high in fibre, fructose, lactose or sweeteners ending in “-ol” ^[6]. MedlinePlus adds treating constipation, noting that soluble fibre such as psyllium is usually better tolerated than bran ^[7].

Over-the-counter options such as simethicone or charcoal capsules are mentioned by MedlinePlus, which notes that charcoal turns stools black ^[7]. NIH advises talking to a doctor before supplements or probiotics ^[6]. Anything taken by mouth still waits at least 30 minutes after Rybelsus®, which is swallowed with plain water only ^[1].

Rybelsus® and Ozempic® are registered trademarks of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.